- Home
- MDAI vs TELA Comparison
MDAI vs TELA Comparison
Compare MDAI & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- TELA
- Stock Information
- Founded
- MDAI 2013
- TELA 2012
- Country
- MDAI United States
- TELA United States
- Employees
- MDAI N/A
- TELA N/A
- Industry
- MDAI Medical/Dental Instruments
- TELA Medical/Dental Instruments
- Sector
- MDAI Health Care
- TELA Health Care
- Exchange
- MDAI Nasdaq
- TELA Nasdaq
- Market Cap
- MDAI 34.8M
- TELA 36.4M
- IPO Year
- MDAI N/A
- TELA 2019
- Fundamental
- Price
- MDAI $1.63
- TELA $1.42
- Analyst Decision
- MDAI Strong Buy
- TELA Strong Buy
- Analyst Count
- MDAI 2
- TELA 4
- Target Price
- MDAI $4.75
- TELA $6.00
- AVG Volume (30 Days)
- MDAI 276.1K
- TELA 148.2K
- Earning Date
- MDAI 05-13-2025
- TELA 05-08-2025
- Dividend Yield
- MDAI N/A
- TELA N/A
- EPS Growth
- MDAI N/A
- TELA N/A
- EPS
- MDAI N/A
- TELA N/A
- Revenue
- MDAI $29,962,000.00
- TELA $71,217,000.00
- Revenue This Year
- MDAI N/A
- TELA $26.37
- Revenue Next Year
- MDAI $86.26
- TELA $22.68
- P/E Ratio
- MDAI N/A
- TELA N/A
- Revenue Growth
- MDAI 55.21
- TELA 12.78
- 52 Week Low
- MDAI $0.82
- TELA $0.86
- 52 Week High
- MDAI $3.25
- TELA $6.00
- Technical
- Relative Strength Index (RSI)
- MDAI 65.66
- TELA 63.47
- Support Level
- MDAI $1.57
- TELA $1.30
- Resistance Level
- MDAI $1.73
- TELA $1.53
- Average True Range (ATR)
- MDAI 0.10
- TELA 0.13
- MACD
- MDAI 0.03
- TELA 0.04
- Stochastic Oscillator
- MDAI 78.26
- TELA 81.48
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.